Lupin Cuts Forecast Despite Etanercept Launch

Firm Sees Trump 'Buy American' Order As Near-Term Opportunity

Earnings Season Company Reports Stock Market Ticker Words 3d Illustration
Lupin's First Quarter Performance Guides Lower FY21 Forecast • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Earnings

More from Business